A new study published in The New England Journal of Medicine showed that Fremanezumab reduced migraine and headache days more than a placebo in children and adolescents with episodic migraine.…
A new study published in the Journal of the American Medical Association showed that for juvenile dermatomyositis (JDM), a combination of intermittent intravenous methylprednisolone pulse and mycophenolate mofetil (MMF) may…
The MAJESTY global phase 3 study evaluating obinutuzumab (Gazyva) in primary membranous nephropathy (PMN) demonstrated positive efficacy and safety outcomes. The trial successfully met its primary endpoint, with patients achieving…
USA: Researchers have found in a recent study that long-term opioid therapy (LTOT) is associated with a modestly increased risk of dental infections. The association, reported in PLOS One, suggests…
Turkey: The year 2025 marked a turning point in dyslipidaemia research, with major advances reshaping how lipid-related cardiovascular risk is understood and managed. In a viewpoint published in the European…
USA: A new study published in the MDPI journal Nutrients has raised concerns about the extent of ultra-processing in commercially available complementary foods for infants and toddlers in the United…
A 10-day dual regimen of vonoprazan and amoxicillin is noninferior to bismuth quadruple therapy for Helicobacter pylori eradication and demonstrates a superior safety profile, as reported in the Journal of…
FDA Commissioner Marty Makary defended the agency’s recent rejections of rare disease drugs and top agency official Vinay Prasad
New Delhi: The Central Drugs Standard Control Organization (CDSCO), under the Directorate General of Health Services (DGHS), Government of India, has issued a circular streamlining the testing of drugs for…
Signalling a zero-tolerance approach towards external pressure, the National Medical Commission has proposed amendments that would allow outright rejection of applications from medical colleges found attempting to influence the regulator…